Thirty-eight patients (median age 77 years; range 62-88 years) with elderly-onset seizures were entered into a single-blind, randomized study designed to compare the impact of phenytoin (PHT) and valproate (VPA) on cognitive function. A stratified minimization program matched the two groups for age, sex, and seizure type. Attention, concentration, psychomotor speed, and memory were assessed twice before treatment (to minimize practice effects), at 6 weeks and (for patients remaining in the study) at 3 months, 6 months, and 1 year by an extensive battery of psychologic tests. Changes in cognitive function were minor, and some tended toward improvement. Contrary to expectation, there was little difference between PHT and VPA with regard to impact on cognitive function. Frequent noncognitive adverse effects were reported. Thus, we did not replicate the findings of previous literature. We conclude that antiepileptic drug (AED) monotherapy as used in our trial did not produce significant adverse cognitive effects. The choice of AED in the elderly may therefore be more influenced by consideration of other adverse effects.
A large primary-care computerized database was searched to determine the incidence and prevalence of epilepsy and epileptic seizures in old age compared with the general population. The prevalence of subjects with a diagnosis of epileptic seizures was higher in older age groups: 10.9/1000 for sexagenarians, 12.0 for septuagenarians and 13.1 for those over 80, compared with 9.0/1000 in the overall population. The overall prevalence in subjects aged over 60 was 11.8. Annual incidence rose even more sharply in old age: 76/100,000 for sexagenarians, 147 for septuagenarians, and 159 for those over 80, compared with an overall population incidence of 69/100,000. The overall incidence in subjects over 60 was 117. Of incident cases requiring treatment, 35.5% were over 60 years old. Our findings are in keeping with other recent epidemiological studies and in part reflect the age-associated increase in the prevalence of cerebrovascular disease. They have implications for the organization of services for elderly people, for the education of general practitioners and hospital doctors and for directing epilepsy research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.